The neurologist’s role in disabling multiple sclerosis: A qualitative study of patient and care provider perspectives

Abstract

Background:

Patients with advanced, disabling multiple sclerosis (MS) have few effective treatment options. Little is known about the role that patients and their care providers want their neurologist to fill in this situation.

Objective:

To better understand the role that patients with disabling MS and their care providers want their neurologist to have in their care.

Methods:

In this exploratory qualitative study, we conducted semi-structured interviews with 29 participants (19 patients with severe disability due to MS and 10 care providers). Interview transcripts were analyzed using inductive thematic analysis.

Results:

Participants identified three main roles for their neurologist: a source of hope for therapeutic advances, an educator about the disease and its management, and a source of support.

Conclusion:

Despite sustaining a level of disability that may be refractory to standard medical therapy, patients with disabling MS and care providers continue to value certain roles of their neurologist. The neurologist’s role as a source of hope and support in particular has not received enough attention in the literature.

Keywords

Multiple sclerosis patient perspective physician role disability care provider

Get full access to this article

View all access options for this article.

References

Abolhassani

Yazdannik

Taleghani

, et al. Expectations of multiple sclerosis patients and their families: A qualitative study in Iran. Iran Red Crescent Med J 2015; 17(2): e18293.

Edmonds

Vivat

Burman

, et al. ‘Fighting for everything’: Service experiences of people severely affected by multiple sclerosis. Mult Scler 2007; 13(5): 660–667.

Galushko

Golla

Strupp

, et al. Unmet needs of patients feeling severely affected by multiple sclerosis in Germany: A qualitative study. J Palliat Med 2014; 17(3): 274–281.

Somerset

Campbell

Sharp

, et al. What do people with MS want and expect from health-care services. Health Expect 2001; 4(1): 29–37.

Feinstein

Freeman

AC.

Treatment of progressive multiple sclerosis: What works, what does not, and what is needed. Lancet Neurol 2015; 14: 194–207.

Meyer-Moock

Feng

Maeurer

, et al. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol 2014; 14: 58.

Baumstarck

Boucekine

Boyer

, et al. Quantification of relevance of quality of life assessment for patients with cognitive impairment: The suitability indices. BMC Neurol 2014; 14: 78.

Baumstarck

Pelletier

Aghababian

, et al. Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study. PLoS ONE 2012; 7(1): e30627.

Baumstarck

Reuter

Boucekine

, et al. Relevance of quality of life assessment for multiple sclerosis patients with memory impairment. PLoS ONE 2012; 7(12): e50056.

10.

Gold

Schulz

Monch

, et al. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 2003; 9: 404–410.

11.

Saunders

Sim

Kingstone

, et al. Saturation in qualitative research: Exploring its conceptualization and operationalization. Qual Quant 2018; 52(4): 1893–1907.

12.

Smith

Symbol Digit Modalities Test (SDMT) manual (revised). Los Angeles, CA: Western Psychological Services, 1982.

13.

Langdon

Amato

Boringa

, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 2012; 18(6): 891–898.

14.

Braun

Clarke

Using thematic analysis in psychology. Qualit Res Psychol 2006; 3: 77–101.

15.

Drake

Weinstock-Guttman

Morrow

, et al. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: Replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 2010; 16(2): 228–237.

16.

Thorne

Con

McGuinness

, et al. Health care communication issues in multiple sclerosis: An interpretive description. Qual Health Res 2004; 14(1): 5–22.

17.

Wollin

Yates

Kristjanson

LJ.

Supportive and palliative care needs identified by multiple sclerosis patients and their families. Int J Palliat Nurs 2006; 12(1): 20–26.

18.

Litzkendorf

Babac

Rosenfeldt

, et al. Information needs of people with rare diseases—What information do patients and their relatives require? J Rare Dis Diagn Ther 2016; 2: 2.

19.

Soundy

Benson

Dawes

, et al. Understanding hope in patients with multiple sclerosis. Physiotherapy 2012; 98(4): 344–350.

20.

Wollin

Dale

Spenser

, et al. What people with newly diagnosed MS (and their families and friends) need to know. Int J Mult Scler Care 2000; 2: 29–39.

21.

Senders

Sando

Wahbeh

, et al. Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs. J Health Psychol 2016; 21(8): 1676–1687.

22.

Montalban

Hauser

Kappos

, et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med 2017; 376(3): 209–220.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB

0.02 MB